BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38633747)

  • 1. Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: the frequency and prognostic impact.
    Vaughan J; Patel M; Suchard M; Gededzha M; Ranchod H; Howard W; Snyman T; Wiggill T
    Front Cell Infect Microbiol; 2024; 14():1340096. PubMed ID: 38633747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma.
    Vaughan J; Wiggill T; Lawrie D; Machaba M; Patel M
    PLoS One; 2023; 18(1):e0280044. PubMed ID: 36630466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
    Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
    Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of regulatory B-cell markers, transforming growth factor β and interleukin-10 as a prognostic factor in diffuse large B-cell lymphoma.
    Mishina T; Miyoshi H; Takeuchi M; Miyawaki K; Nakashima K; Yamada K; Moritsubo M; Inoue-Mitsuyama K; Shimasaki Y; Imamoto T; Kawamoto K; Furuta T; Kohno K; Kato K; Akashi K; Ohshima K
    Pathol Res Pract; 2024 Feb; 254():155117. PubMed ID: 38262270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and Prognostic Value of Cytokines in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma].
    Man Y; Ge CQ; Li ZZ; Yang TH; Wang YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1050-1055. PubMed ID: 37551476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
    Troppan KT; Schlick K; Deutsch A; Melchardt T; Egle A; Stojakovic T; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Pichler M
    Br J Cancer; 2014 Jul; 111(1):55-60. PubMed ID: 24874478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and prognostic features of 63 HIV-associated diffuse large B-cell lymphoma: a single-center real-world study in China].
    Wang CY; Liu J; Liang XP; Guo BL; Hu RZ; Liu Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):203-208. PubMed ID: 35405777
    [No Abstract]   [Full Text] [Related]  

  • 8. IDO, TDO, and AHR overexpression is associated with poor outcome in diffuse large B-cell lymphoma patients in the rituximab era.
    Chen X; Zang Y; Li D; Guo J; Wang Y; Lin Y; Wei Z
    Medicine (Baltimore); 2020 May; 99(21):e19883. PubMed ID: 32481253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma.
    Kim DJ; Kim T; Jeong JY; Jo JC; Lee WS; Shin HJ; Lee JH; Lee HS
    Int J Hematol; 2020 Apr; 111(4):559-566. PubMed ID: 31907736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphoma.
    Xie S; Zhu L; Wang L; Wang S; Tong X; Ni W
    Oncol Lett; 2024 May; 27(5):237. PubMed ID: 38601181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
    Wang C; Wu Y; Liu J; Min H; Huang Y; Wei G; Zhang W; Wang M; Tang X; Zhou H; Chen Y; Liu Y
    Front Immunol; 2023; 14():1153790. PubMed ID: 37063928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma.
    Lu YS; Chiang PM; Huang YC; Yang SJ; Hung LY; Medeiros LJ; Chen YP; Chen TY; Chang MS; Chang KC
    Pathology; 2023 Feb; 55(1):94-103. PubMed ID: 36175183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
    Cassim S; Antel K; Chetty DR; Oosthuizen J; Opie J; Mohamed Z; Verburgh E
    Pathology; 2020 Jun; 52(4):453-459. PubMed ID: 32305135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Anemia and C-Reactive Protein Levels in Diffuse Large B-Cell Lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):671-9. PubMed ID: 26361646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.
    Nakayama S; Matsuda M; Adachi T; Sueda S; Ohashi Y; Awaji S; Hashimoto S; Matsumura I
    Platelets; 2019; 30(5):637-645. PubMed ID: 30047815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
    Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
    Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large cell lymphoma: correlation of HIV status and prognosis with differentiation profiles assessed by immunophenotyping.
    Pather S; Mohamed Z; McLeod H; Pillay K
    Pathol Oncol Res; 2013 Oct; 19(4):695-705. PubMed ID: 23670212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma.
    Han X; Wang J; Zhang N; Yao J; Feng Y; Li D; Liu P; Yang J; Zhou S; Qin Y; Yang S; Gui L; He X; Shi Y
    Leuk Res; 2014 Nov; 38(11):1291-8. PubMed ID: 25287608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.